Literature DB >> 20582762

The HPV vaccination strategy: could male vaccination have a significant impact?

V Brown1, K A J White.   

Abstract

We investigate the potential success of the human papilloma virus (HPV) vaccine, taking into consideration possible waning immunity and the influence of behavioural parameters. We use a compartmental, population-level ordinary differential equation (ODE) model. We find the effective reproductive value for HPV, Re0, which measures the threshold for infection outbreak in a population that is not entirely susceptible, together with infection prevalence. We study the effects of different parameters on both of these quantities. Results show that waning immunity plays a large part in allowing infection to persist. The proportion of the population not sexually active when vaccination occurs affects Re0, as does the rate at which individuals become sexually active. In several cases, infection persists as a result of an infection reservoir in the male cohort. To explore this further, we introduce male vaccination and find the conditions for which vaccination of males could be considered appropriate.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20582762     DOI: 10.1080/17486700903486613

Source DB:  PubMed          Journal:  Comput Math Methods Med        ISSN: 1748-670X            Impact factor:   2.238


  4 in total

1.  Human papillomavirus vaccination in males: the state of the science.

Authors:  Luis F Barroso; Timothy Wilkin
Journal:  Curr Infect Dis Rep       Date:  2011-04       Impact factor: 3.725

Review 2.  Aspects of prophylactic vaccination against cervical cancer and other human papillomavirus-related cancers in developing countries.

Authors:  Kari Natunen; Johannes Lehtinen; Proscovia Namujju; John Sellors; Matti Lehtinen
Journal:  Infect Dis Obstet Gynecol       Date:  2011-07-19

3.  Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models.

Authors:  Johannes A Bogaards; Mirjam Kretzschmar; Maria Xiridou; Chris J L M Meijer; Johannes Berkhof; Jacco Wallinga
Journal:  PLoS Med       Date:  2011-12-20       Impact factor: 11.069

4.  Examining Provincial HPV Vaccination Schemes in Canada: Should We Standardise the Grade of Vaccination or the Number of Doses?

Authors:  Carley Rogers; Robert J Smith
Journal:  Int Sch Res Notices       Date:  2015-04-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.